Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Novanta | NOVT | 5. nov 2024 | 164.67 | -5.45 |
Novartis ADR | NVS | 5. nov 2024 | 109.38 | -1.03 |
Novavax | NVAX | 5. nov 2024 | 9.44 | +3.51 |
Novo Integrated Sciences | NVOS | 5. nov 2024 | 0.17 | 0.00 |
Novo Nordisk ADR | NVO | 5. nov 2024 | 110.13 | +0.37 |
NovoCure | NVCR | 5. nov 2024 | 16.62 | +0.18 |
Novonix ADR | NVX | 5. nov 2024 | 1.76 | +2.92 |
NRG Energy | NRG | 5. nov 2024 | 91.25 | +3.63 |
NRx Pharmaceuticals | NRXP | 5. nov 2024 | 1.27 | -3.79 |
NSTS Bancorp | NSTS | 5. nov 2024 | 10.92 | -1.38 |
Nu Holdings | NU | 5. nov 2024 | 14.67 | +2.09 |
Nu Skin Enterprises | NUS | 5. nov 2024 | 6.43 | +1.42 |
Nuburu | BURU | 5. nov 2024 | 0.53 | +1.15 |
NuCana ADR | NCNA | 5. nov 2024 | 1.53 | -1.29 |
Nucor | NUE | 5. nov 2024 | 144.61 | +1.41 |
Nukkleus | NUKK | 5. nov 2024 | 2.34 | +3.08 |
Nurix Therapeutics | NRIX | 5. nov 2024 | 25.43 | +1.56 |
NuScale Power | SMR | 5. nov 2024 | 18.82 | +1.90 |
Nustar Energy C Pref | NS-C | 5. nov 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | 5. nov 2024 | 64.50 | +3.18 |
Nutex Health | NUTX | 5. nov 2024 | 25.00 | +8.51 |
Nutriband | NTRB | 5. nov 2024 | 5.30 | -8.78 |
Nutrien | NTR | 5. nov 2024 | 50.63 | -0.30 |
Nuvalent A | NUVL | 5. nov 2024 | 91.91 | +2.66 |
Nuvation Bio A | NUVB | 5. nov 2024 | 2.32 | +1.31 |
Nuvectis Pharma | NVCT | 5. nov 2024 | 7.43 | +17.75 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | 5. nov 2024 | 12.64 | +0.56 |
Nuveen Amtfree Municipal Value Fund | NUW | 5. nov 2024 | 13.90 | +0.58 |
Nuveen Amtfree Quality Municipal Income Fund | NEA | 5. nov 2024 | 11.47 | +1.06 |
Nuveen Arizona Quality Municipal Fund | NAZ | 5. nov 2024 | 11.81 | -0.09 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.